Back to top
more

Baxter International (BAX)

(Delayed Data from NYSE)

$35.87 USD

35.87
3,167,156

+0.17 (0.48%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $35.75 -0.12 (-0.33%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Varian Medical (VAR) to Report Q1 Earnings: What's in Store?

Strong overseas presence and product launches are likely to aid Varian Medical's (VAR) fiscal first-quarter results.

Stock Market News For Jan 8, 2019

Wall Street rallied for the second consecutive day on Monday after resumption of trade related negotiations between the United States and China

Baxter's PD Solution to Treat Patients, Prospects Bright

Baxter's (BAX) kidney care portfolio likely to favor the company as kidney care demand shoots up in the United States.

Can Baxter (BAX) Keep the Earnings Surprise Streak Alive?

Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III

Mallinckrodt (MNK) and partner NPXe Limited enrol the first patient in the phase III study on xenon gas for inhalation (XENEX) for Post Cardiac Arrest Syndrome (PCAS).

Stock Market News For Dec 19, 2018

U.S. stocks closed mostly higher on Tuesday after a volatile session, reversing stiff decline in previous two trading days

Baxter Stock up on Launch of Disposable Curved Applicator

Baxter's (BAX) wide array of surgical products see lucrative market prospects.

Here's Why You Should Hold Baxter International (BAX) Now

Baxter's (BAX) recent string of developments boost the stock while segmental softness is a concern.

Baxter & EFCNI Collaborate to Improve Care for Preterm Born

Baxter's (BAX) latest move is likely to increase the use of Baxter's Numeta G13E triple-chamber PN product.

Why Is Baxter (BAX) Up 7.9% Since Last Earnings Report?

Baxter (BAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Baxter (BAX) Launches Peri-Strips & Tisseel Prima, Shares Up

Baxter's (BAX) diversified surgical portfolio lends it a competitive edge in the MedTech space.

Company News For Nov 1, 2018

Companies In The News Are: TMUS,S,K,BAX

Mark Vickery headshot

Top Analyst Reports for Amazon, Facebook, Mastercard & Merck

Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Facebook (FB), Mastercard (MA) and Merck (MRK).

Baxter (BAX) Earnings Beat, Revenues Lag Estimates in Q3

Baxter (BAX) gains from Renal Care and Advanced Surgery units in Q3; APAC sales soft.

Baxter International (BAX) Tops Q3 Earnings Estimates

Baxter (BAX) delivered earnings and revenue surprises of 8.11% and -0.67%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Medical Product Stock Q3 Earnings on Oct 31: BAX, MASI & More

Long-term growth prospects of the Medical Products industry looks promising despite certain short-term political conundrums.

Zimmer Biomet (ZBH) Q3 Earnings Top Estimates, Margins Down

We are encouraged by Zimmer Biomet's (ZBH) consistent effort in product renovation through research and development.

Cerner's (CERN) Q3 Earnings Match Estimates, Bookings Up Y/Y

Cerner (CERN) gains from strong segmental revenues in the third quarter. Guidance for 2018 is impressive.

Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q3

Omnicell's (OMCL) third-quarter 2018 performance impresses with year-over-year growth in earnings and revenues.

ResMed (RMD) Q1 Earnings & Sales Beat on Overall Growth

ResMed (RMD) sees solid contributions from domestic and international businesses in Q1.

Merit Medical (MMSI) Tops Q3 Earnings & Revenue Estimates

Merit Medical (MMSI) gains from solid segmental performance in Q3. Also, the company reiterated its guidance for 2018.

Stryker (SYK) Beats Q3 Earnings, Misses Sales Estimates

Stryker's (SYK) Q3 results benefit from solid segmental performance. Also, the company sustained strength in International sales.

Will Advance Medical Buyout Aid Teladoc (TDOC) Q3 Earnings?

Teladoc (TDOC) is expected to chip in with a solid top-line contribution from its acquisition of Advance Medical in Q3.

Can CAG Growth Steadily Drive IDEXX (IDXX) in Q3 Earnings?

IDEXX's (IDXX) efforts to enhance its commercial capabilities in the United States to maintain a recurring revenue rise at CAG Diagnostics are encouraging.

Will Product Revenues Drive Masimo's (MASI) Q3 Earnings?

Masimo's (MASI) Product revenues likely to drive Q3; guidance for 2018 raised.